GH Research PLC (NASDAQ:GHRS) Short Interest Up 8.1% in July

GH Research PLC (NASDAQ:GHRS) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 1,460,000 shares, a growth of 8.1% from the June 30th total of 1,350,000 shares. Approximately 4.8% of the company’s stock are short sold. Based on an average trading volume of 50,600 shares, the short-interest ratio is presently 28.9 days.

Institutional Investors Weigh In On GH Research

Large investors have recently modified their holdings of the stock. BVF Inc. IL lifted its holdings in GH Research by 12.1% during the 4th quarter. BVF Inc. IL now owns 10,400,158 shares of the company’s stock valued at $60,321,000 after purchasing an additional 1,125,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of GH Research by 14.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 106,363 shares of the company’s stock worth $617,000 after buying an additional 13,579 shares in the last quarter. AdvisorShares Investments LLC raised its stake in shares of GH Research by 4.3% in the fourth quarter. AdvisorShares Investments LLC now owns 48,300 shares of the company’s stock valued at $280,000 after acquiring an additional 1,977 shares during the last quarter. Lynx1 Capital Management LP boosted its holdings in shares of GH Research by 80.1% in the 1st quarter. Lynx1 Capital Management LP now owns 3,310,563 shares of the company’s stock worth $35,291,000 after acquiring an additional 1,471,946 shares in the last quarter. Finally, RA Capital Management L.P. boosted its holdings in shares of GH Research by 11.9% in the 1st quarter. RA Capital Management L.P. now owns 6,251,714 shares of the company’s stock worth $66,643,000 after acquiring an additional 664,381 shares in the last quarter. 56.90% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on GHRS. HC Wainwright restated a “buy” rating and set a $40.00 price target on shares of GH Research in a report on Wednesday. Canaccord Genuity Group upped their price target on GH Research from $30.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 6th.

GH Research Trading Up 2.7 %

GH Research stock traded up $0.33 on Thursday, hitting $12.73. The company’s stock had a trading volume of 572 shares, compared to its average volume of 94,543. The company has a fifty day moving average price of $12.25 and a 200-day moving average price of $10.58. GH Research has a one year low of $5.05 and a one year high of $14.99.

GH Research (NASDAQ:GHRS) last posted its earnings results on Friday, May 3rd. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.07. On average, analysts expect that GH Research will post -0.84 EPS for the current year.

About GH Research

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).